PROVIDER PROFILE · NPI 1972829349

Christopher CarrMD

DermatologyDallas, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

5,394

Unique beneficiaries

—

Total services

9,504

Distinct HCPCS

Medicare payment

$416K

Peer benchmark

Total Medicare services vs. 965 Dermatology providers in TX — top quintile (cohort median 2,537).

PRESCRIBING · PART D · 2024

Total Rx claims

1,279

Beneficiaries

—

Total drug cost

$336K

Distinct drugs

Brand share

7.4%

Top prescribed drugs

Ketoconazole404 claims

Triamcinolone Acetonide198 claims

Clobetasol Propionate142 claims

Mupirocin84 claims

Fluorouracil61 claims

QUALITY · MIPS · 2024

Final MIPS score

95.7

Quality

92.2

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.87%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$3K

Payment records

150

By payment type

Food and Beverage$3K

Top paying entities

Food and Beverage$3K

REFERRAL NETWORK

Where Christopher Carr's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Prasanna Sinkre Pathology · Dallas, TX	235	350
BAYLOR UNIVERSITY MEDICAL CENTER	49	66
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	39	61
Youcef Sennour Geriatric Medicine · Lebanon, NH	13	45
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	11	12

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history